Teleflex inflates portfolio but shrinks FY13 revenue prospects yet again
This article was originally published in Clinica
Executive Summary
Teleflex has lowered its full-year revenue guidance for the second time this year, due to lackluster sales in certain business units and anticipated distributor issues in Asia which are likely to weigh on the current quarter’s results.